Cardiogenetic testing: when CVD risk is hereditary
In many patients, the risk of cardiovascular disease (CVD) may be attributed to genetic polymorphisms and mutations. Quest Diagnostics offers cardiogenetic testing to aid in early diagnosis and earlier treatment for affected patients, as well as family members.
Familial hypercholesterolemia
Familial hypercholesterolemia (FH) refers to a group of genetic defects resulting in severe elevations of blood cholesterol levels and increased risk of premature coronary heart disease (CHD). These defects are found in the FH genes that encode for low density lipoprotein receptor (LDLR), Apolipoprotein B (APOB), and proprotein convertase subtilisin/kexin type 9 (PCSK9), and possibly others.
Today, FH is generally underdiagnosed and undertreated. With the help of genetic testing, you can change that trend. Genetic testing for FH from Quest detects mutations on the LDLR, ApoB, and PCSK9 genes to enable an early, specific diagnosis of FH.
Learn more about FH genetic testing
FH Forms and Letters of Medical Necessity
Other cardiogenetic markers
Cardiogenetic testing helps provide deeper insight into genetic risk of CVD as well as therapy selection.
This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.
Questions?
Your Quest account representative can provide additional information on our cardiovascular testing solutions.
Cardiovascular disease
Cardiovascular
-
Advanced lipid testing -
Identifying residual risk -
Inflammation testing -
Advanced inflammatory marker testing -
Metabolic testing -
Metabolic testing portfolio -
Cardiogenetic testing -
Heart failure -
Focus on earlier identification of heart failure risk -
Non-lipid markers for CVD -
Important genotyping -
CVD test descriptions -
4myheart® program -
Cardio IQ® report -
Early identification of CVD risk in women
Save time & fix billing issues
Avoid disruptions and reduce paperwork with electronic billing trailers.
Raise patient satisfaction and get the insights you need
Access better patient tools, view test offerings, improve your bottom line, and more.
- Site map
- Privacy Notices
- Terms
- Contact us
- Language assistance / non-discrimination
- Asistencia de idiomas / Aviso de no discriminación
- 語言協助 / 不歧視通知
- Accessibility
-
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.